Priscilla Do - Concepedia

Author

Priscilla Do

The Ohio State University

Also Known As

Priscilla Do

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University University of Notre Dame Emory University University of Pennsylvania Harvard University

About

Priscilla Do is an author at The Ohio State University specializing in immunology, immunotherapy, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	100
2	Immunology	3	3	100
3	Cell Biology	2	2	66
4	Biomolecular Engineering	1	1	34
5	Molecular Biology	1	1	34

Priscilla Do

Publications

993

Citations

H-Index

Page 1

	Year	Citations
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia Joseph A. Fraietta, Kyle A. Beckwith, Prachi Patel, Blood	2016	450
Ibrutinib treatment improves T cell number and function in CLL patients Meixiao Long, Kyle A. Beckwith, Priscilla Do, Journal of Clinical Investigation	2017	362
Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity Natalie A. Bowerman, Terence S. Crofts, Lukasz K. Chlewicki, Molecular Immunology Signal TransductionT-regulatory CellImmunologyAntigen ProcessingAutoimmunity	2009	41
Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner Kurt H. Piepenbrink, Oleg Y. Borbulevych, Ruth F. Sommese, Biochemical Journal Peptide EngineeringImmunologyMolecular BiologyAntigen ProcessingPeptide Science	2009	34
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells Priscilla Do, Kyle A. Beckwith, Carolyn Cheney, The Journal of Immunology	2019	34
Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A0201: Implications for WT1-based cancer therapeutics Oleg Y. Borbulevych, Priscilla Do, Brian M. Baker Molecular Immunology MedicineAffinity-enhanced Wt1ImmunologyImmunoeditingHla Typing	2010	25
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia Eileen Hu, Priscilla Do, Swagata Goswami, Blood Advances	2021	25
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12 Rae Hunter, Kathleen J. Imbach, Chengjing Zhou, Scientific Reports	2022	22

Page 1